280 related articles for article (PubMed ID: 26165841)
1. Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis.
Lee S; Kim W; Ko C; Ryu WS
Oncogene; 2016 Apr; 35(14):1857-67. PubMed ID: 26165841
[TBL] [Abstract][Full Text] [Related]
2. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
[TBL] [Abstract][Full Text] [Related]
3. The X protein of hepatitis B virus binds to the F box protein Skp2 and inhibits the ubiquitination and proteasomal degradation of c-Myc.
Kalra N; Kumar V
FEBS Lett; 2006 Jan; 580(2):431-6. PubMed ID: 16376880
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein activates E3 ubiquitin ligase Siah-1 to control virus propagation via a negative feedback loop.
Yeom S; Kim SS; Jeong H; Jang KL
J Gen Virol; 2017 Jul; 98(7):1774-1784. PubMed ID: 28714848
[TBL] [Abstract][Full Text] [Related]
5. DDB1 Stimulates Viral Transcription of Hepatitis B Virus via HBx-Independent Mechanisms.
Kim W; Lee S; Son Y; Ko C; Ryu WS
J Virol; 2016 Nov; 90(21):9644-9653. PubMed ID: 27535046
[TBL] [Abstract][Full Text] [Related]
6. The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7.
Morel M; Shah KN; Long W
J Biol Chem; 2020 Jun; 295(23):7970-7980. PubMed ID: 32345600
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system.
Chen G; Wang Y; Garate M; Zhou J; Li G
Oncogene; 2010 Mar; 29(10):1498-508. PubMed ID: 19935701
[TBL] [Abstract][Full Text] [Related]
8. Expression of pituitary tumor-transforming gene 1 (PTTG1)/securin in hepatitis B virus (HBV)-associated liver diseases: evidence for an HBV X protein-mediated inhibition of PTTG1 ubiquitination and degradation.
Molina-Jiménez F; Benedicto I; Murata M; Martín-Vílchez S; Seki T; Antonio Pintor-Toro J; Tortolero M; Moreno-Otero R; Okazaki K; Koike K; Barbero JL; Matsuzaki K; Majano PL; López-Cabrera M
Hepatology; 2010 Mar; 51(3):777-87. PubMed ID: 20198633
[TBL] [Abstract][Full Text] [Related]
9. Histone acetyltransferase CBP promotes function of SCF FBXL19 ubiquitin E3 ligase by acetylation and stabilization of its F-box protein subunit.
Wei J; Dong S; Yao K; Martinez MFYM; Fleisher PR; Zhao Y; Ma H; Zhao J
FASEB J; 2018 Aug; 32(8):4284-4292. PubMed ID: 29522376
[TBL] [Abstract][Full Text] [Related]
10. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
[TBL] [Abstract][Full Text] [Related]
11. Lysine-52 stabilizes the MYC oncoprotein through an SCF
De Melo J; Kim SS; Lourenco C; Penn LZ
Oncogene; 2017 Dec; 36(49):6815-6822. PubMed ID: 28806398
[TBL] [Abstract][Full Text] [Related]
12. Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis.
Kim YC; Song KS; Yoon G; Nam MJ; Ryu WS
Oncogene; 2001 Jan; 20(1):16-23. PubMed ID: 11244501
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus HBx Protein Mediates the Degradation of Host Restriction Factors through the Cullin 4 DDB1 E3 Ubiquitin Ligase Complex.
Minor MM; Hollinger FB; McNees AL; Jung SY; Jain A; Hyser JM; Bissig KD; Slagle BL
Cells; 2020 Mar; 9(4):. PubMed ID: 32235678
[TBL] [Abstract][Full Text] [Related]
14. HBx regulates transcription factor PAX8 stabilization to promote the progression of hepatocellular carcinoma.
Wang J; Li N; Huang ZB; Fu S; Yu SM; Fu YM; Zhou PC; Chen RC; Zhou RR; Huang Y; Hu XW; Fan XG
Oncogene; 2019 Oct; 38(40):6696-6710. PubMed ID: 31391550
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase Siah-1 facilitates poly-ubiquitylation and proteasomal degradation of the hepatitis B viral X protein.
Zhao J; Wang C; Wang J; Yang X; Diao N; Li Q; Wang W; Xian L; Fang Z; Yu L
FEBS Lett; 2011 Oct; 585(19):2943-50. PubMed ID: 21878328
[TBL] [Abstract][Full Text] [Related]
16. ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression.
Li X; Bian Y; Takizawa Y; Hashimoto T; Ikoma T; Tanaka J; Kitamura N; Inagaki Y; Komada M; Tanaka T
Mol Cancer Res; 2013 Nov; 11(11):1437-47. PubMed ID: 24177224
[TBL] [Abstract][Full Text] [Related]
17. Stratifin Inhibits SCF
Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M
Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155
[TBL] [Abstract][Full Text] [Related]
18. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
[TBL] [Abstract][Full Text] [Related]
19. E3 ubiquitin ligase TRIM21 restricts hepatitis B virus replication by targeting HBx for proteasomal degradation.
Song Y; Li M; Wang Y; Zhang H; Wei L; Xu W
Antiviral Res; 2021 Aug; 192():105107. PubMed ID: 34097931
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein upregulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2.
Li W; Miao X; Qi Z; Zeng W; Liang J; Liang Z
Virol J; 2010 Feb; 7():45. PubMed ID: 20170530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
